User:Liebermannda

Dan Liebermann is a cancer biologist, currently professor of the Fels Institute for Cancer research and Molecular Biology and Professor of the Department of Biochemistry at the Temple University School of Medicine. Dan Liebermann has made seminal discoveries in the fields of Cancer Biology, Leukemia, Hematopoiesis and Molecular Biology. His laboratory, in collaboration with Dr. Barbara Hoffman (Professor of the Fels and Biochemistry Temple University School of Medicine) has pioneered research in Early Growth Response (EGR), Myeloid Differentiation (MyD) and Growth Arrest and DNA Damage (GADD) primary response genes related to genetic changes associated with normal cell development and oncogenesis. He is considered as one of the discoveres of the Gadd45 family of genes, including Gadd45a,Gadd45b (MyD118) and Gadd45g (CR6)     ,  discoverer of the Toll receptor MyD88 gene , and the growth arrest pro-apoptotic gadd34/MyD116 gene. He was also among the first to document the finding that the pro-apoptotic protein BAX is a target of the p53 tumor suppressor.